™Your Policy Risk Impact Agent
84 chapters · 1,726 sections in this title.
18 Del. C. § 3373. Utilization review entity’s obligation with respect to pre-authorization [For application of this section, see 85 Del. Laws, c. 176, § 4].
4.2K chars
§ 3373. Utilization review entity’s obligation with respect to pre-authorization [For application of this section, see 85 Del. Laws, c. 176, § 4]. (a) If a utilization review entity requires pre-authorization of a pharmaceutical, the utilization review entity must complete its pr…
18 Del. C. § 3374. Utilization review entity’s obligations with respect to pre-authorization concerning emergency health-care services.
0.3K chars
§ 3374. Utilization review entity’s obligations with respect to pre-authorization concerning emergency health-care services. A utilization review entity must follow all emergency procedures and mandates as delineated in §§ 3349 and 3565 of this title.80 Del. Laws, c. 310, § 1;
18 Del. C. § 3375. Retrospective denial.
0.6K chars
§ 3375. Retrospective denial. The utilization review entity may not revoke, limit, condition or restrict a pre-authorization on ground of medical necessity after the date the health-care provider received the pre-authorization. Any language attempting to disclaim payment for serv…
18 Del. C. § 3376. Effect and length of pre-authorization; limitation per episode of care [For application of this section, see 85 Del. Laws, c. 176, § 4].
1.6K chars
§ 3376. Effect and length of pre-authorization; limitation per episode of care [For application of this section, see 85 Del. Laws, c. 176, § 4]. (a) A pre-authorization for pharmaceuticals shall be valid for 1 year from the date the health-care provider receives the pre-authoriza…